Politico that she opposes a plan to let Medicare negotiate prescription drug prices, which would save the government billions and free up money to fund other social programs.
The plan is part of the budget reconciliation bill currently pending in the Senate; Sinema, one of the biggest recipients of pharmaceutical company contributions, has not commented on the record about it.
It’s also been reported that she told Biden she won’t support the budget reconciliation bill overall if a bill on rebuilding infrastructure isn’t passed first.